Trelegy Ellipta: what it treats, how to use it, side effects
Last updated September 3, 2026.
Trelegy Ellipta packs three maintenance medicines into one once-daily inhalation: fluticasone furoate (inhaled steroid), umeclidinium (a LAMA), and vilanterol (a LABA). It is the single-inhaler answer for COPD and asthma patients whose disease is not controlled on two-drug combinations, replacing what used to be a two- or three-inhaler routine.
What does it treat?
Maintenance treatment of COPD (100/62.5/25 mcg) and of asthma in adults 18 and older (100/62.5/25 or 200/62.5/25 mcg). Triple therapy earns its place when symptoms or exacerbations persist despite dual therapy: the steroid fights inflammation, the LAMA and LABA open airways by two different mechanisms. It is not for acute attacks; it prevents them.
How do you take it?
One inhalation once daily, same time every day, maximum one per 24 hours. The Ellipta technique: slide the cover down to the click, exhale away from the device, inhale long, steady, and deep, hold, breathe out slowly. Rinse with water and spit after each dose to prevent thrush. Missed dose: inhale when remembered unless the next dose is near; never double up. Do not stack other LABA or LAMA inhalers on top of it; it already contains both.
Side effects to know
- Common: upper-respiratory infections, pneumonia (the ICS component, in COPD), oral thrush, headache, back pain, joint pain, sinusitis, altered taste, and constipation or urinary tract infection (the anticholinergic LAMA at work).
- Serious: the LABA class warning in asthma, paradoxical bronchospasm, pneumonia, adrenal and bone effects of chronic steroids, eye problems (glaucoma, cataracts), and the LAMA cautions: urinary retention, especially with prostate enlargement, and worsening narrow-angle glaucoma.
Who should not take it?
Not for acute bronchospasm, and not with severe milk-protein allergy (lactose carrier). Narrow-angle glaucoma and urinary retention or significant prostate enlargement are the LAMA-driven cautions. Strong CYP3A4 inhibitors raise steroid levels. If your other inhalers already contain a LABA (vilanterol, salmeterol, formoterol) or LAMA (tiotropium, umeclidinium), those stop when Trelegy starts; doubling up is a medication error, not a boost.
When is it an emergency?
Call 911 for immediate worsening of breathing after a dose, facial swelling or trouble breathing, an asthma or COPD attack your rescue inhaler does not touch, or sudden eye pain with halos. Inability to urinate needs same-day care. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Why three drugs in one inhaler?
Because they attack airway disease from three directions at once: the steroid reduces inflammation, the LAMA (umeclidinium) blocks the airway-narrowing acetylcholine signal, and the LABA (vilanterol) relaxes airway muscle directly. For patients still symptomatic on two mechanisms, adding the third measurably cuts exacerbations, and one device beats three.
Do I keep my other inhalers when I switch?
The maintenance ones, no: Trelegy already contains their drug classes, and continuing a LABA or LAMA on the side double-doses you. Your rescue inhaler (albuterol) absolutely stays; Trelegy is prevention, and the label says clearly it is not for acute bronchospasm.
Is Trelegy only for COPD?
No: it is also approved for asthma in adults 18 and older whose control is inadequate on ICS/LABA combinations. The asthma approval is newer than the COPD one, which is why many people still associate it with COPD only.
Why the rinse-and-spit routine?
Same reason as any inhaled steroid: fluticasone residue in the mouth breeds thrush and hoarseness, and rinsing with water (spit, never swallow) after each dose prevents most of it. It is a 10-second habit that saves a fungal infection.
I have an enlarged prostate. Is that a problem?
It is a flag, not necessarily a stop sign. The umeclidinium component is anticholinergic and can worsen urinary retention in prostate enlargement. Many men with BPH use it fine with monitoring, but new difficulty urinating on Trelegy is a call-your-doctor symptom, and your prescriber should know the prostate history upfront.
How soon should I feel different?
Bronchodilation starts the first day, but the full anti-inflammatory and exacerbation-prevention benefits build over weeks. Judge it at 4 to 8 weeks by the numbers that matter: rescue-inhaler use, night symptoms, activity tolerance. It is a long game device, and stopping because week one felt ordinary is the classic mistake.